Efficacy of SCH56592 in a rabbit model of invasive aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 780-782

  Kirkpatrick, William R ^a   McAtee, Robert K ^a   Fothergill, Annette W ^a   Loebenberg, David ^b   Rinaldi, Michael G ^a,c   Patterson, Thomas F ^a,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SURVIVAL;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSION; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; RABBITS; TRIAZOLES;

EID: 0033998525     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.780-782.2000     Document Type: Article

References (17)

1. Connolly, P., J. Wheat, C. Schnizlein-Bick, M. Durkin, S. Kohler, M. Smedema, J. Goldberg, E. Brizendine, and D. Loebenburg. 1999. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob. Agents Chemother. 43:322-328.
2. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-805.
3. Denning, D. W., S. A. Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
4. Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956.
5. Graybill, J. R. 1989. New antifungal agents. Eur. J. Clin. Microbiol. Infect. Dis. 5:402-412.
6. Graybill, J. R., R. Bocanegra, L. K. Najvar, M. F. Luther, and D. Loebenberg. 1998. SCH56592 treatment of murine invasive aspergillosis. J. Antimicrob. Chemother. 42:539-542.
7. Graybill, J. R., and S. R. Kaster. 1984. Experimental murine aspergillosis: comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. Am. Rev. Respir. Dis. 129:292-295.
8. Latgé, J.-P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
9. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Oakley, K. L., G. Morrissey, and D. W. Denning. 1997. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1504-1507.
11. Odds, T. C., F. Van Gerven, A. Espinel-Ingroff, M. S. Bartlett, M. A. Ghannoum, M. V. Lancaster, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, and T. J. Walsh. 1998. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob. Agents Chemother. 42:282-288.
12. Patterson, T. F., A. W. Fothergill, and M. G. Rinaldi. 1993. The efficacy of itraconazole solution in experimental invasive aspergillosis. Antimicrob. Agents Chemother. 37:2307-2310.
13. Patterson, T. F., D. George, R. Ingersoll, P. Miniter, and V. T. Andriole. 1991. The efficacy of SCH-39304 in experimental invasive aspergillosis. Antimicrob. Agents Chemother. 35:1985-1988.
14. Patterson, T. F., P. Miniter, J. Dijkstra, F. C. Szoka, J. L. Ryan, and V. T. Andriole. 1989. Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J. Infect. Dis. 159:717-724.
15. Patterson, T. F., P. Miniter, J. L. Ryan, and V. T. Andriole. 1988. Effect of immunosuppression and amphotericin B on aspergillus antigenemia in an experimental model. J. Infect. Dis. 158:415-422.
16. Sabetta, J. R., P. Miniter, and V. T. Andriole. 1985. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J. Infect. Dis. 152:946-953.
17. Sugar, A. M., and L. Xiu-Ping. 1996. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob. Agents Chemother. 40:1314-1316.